Pureland Global Venture

Pureland Global Venture is a leading global healthcare venture capital firm dedicated to driving medical innovation and delivering impactful solutions worldwide. As a designated co-investment partner, Pureland Global Venture is committed to supporting visionary entrepreneurs who are addressing critical healthcare challenges with integrity and ingenuity. Focused on early to growth-stage investments, Pureland Global Venture specializes in sectors such as medical devices, digital health, healthcare services, and AI-empowered solutions. The firm's interests span key areas including oncology, ophthalmology, brain health, orthopedics, cardiology, and chronic disease management.

With a globally diversified portfolio, Pureland Global Venture strategically allocates investments across the U.S., Singapore, India, and the EU. Beyond financial backing, Pureland Global Venture provides comprehensive post-investment support, focusing on strategy development, distribution, cross-border expansion, and manufacturing/OEM partnerships. The firm's primary address is located at 1 Sims Lane, Singapore, 387355, SG.

Pureland Global Venture strives to create a collaborative ecosystem that fosters partnerships among start-ups, government bodies, clinical, investment, and commercial entities. This holistic approach ensures that portfolio companies receive the necessary resources and guidance to achieve sustainable growth and make significant contributions to the healthcare sector. We invite the management of Pureland Global Venture to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and reach.